Exenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes/macrophages.
about
Exploiting the Pleiotropic Antioxidant Effects of Established Drugs in Cardiovascular DiseaseEasy-to-use strategy for reference gene selection in quantitative real-time PCR experiments.Metformin reduces the expression of NADPH oxidase and increases the expression of antioxidative enzymes in human monocytes/macrophages cultured in vitro.Extrapancreatic effects of incretin hormones: evidence for weight-independent changes in morphological aspects and oxidative status in insulin-sensitive organs of the obese nondiabetic Zucker rat (ZFR).Exendin-4 in combination with adipose-derived stem cells promotes angiogenesis and improves diabetic wound healing.Exenatide and metformin express their anti-inflammatory effects on human monocytes/macrophages by the attenuation of MAPKs and NFκB signaling.
P2860
Exenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes/macrophages.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Exenatide (a GLP-1 agonist) im ...... d human monocytes/macrophages.
@ast
Exenatide (a GLP-1 agonist) im ...... d human monocytes/macrophages.
@en
type
label
Exenatide (a GLP-1 agonist) im ...... d human monocytes/macrophages.
@ast
Exenatide (a GLP-1 agonist) im ...... d human monocytes/macrophages.
@en
prefLabel
Exenatide (a GLP-1 agonist) im ...... d human monocytes/macrophages.
@ast
Exenatide (a GLP-1 agonist) im ...... d human monocytes/macrophages.
@en
P2093
P2860
P50
P1476
Exenatide (a GLP-1 agonist) im ...... ed human monocytes/macrophages
@en
P2093
Krzysztof Łabuzek
Rafał Jakub Bułdak
Łukasz Bułdak
P2860
P2888
P304
P356
10.1007/S00210-015-1124-3
P577
2015-05-19T00:00:00Z